Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 11/20 | 0.66 |
| ▸ | EGFR | P00533 | 10/20 | 0.58 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7006741 | 1.00 | ERBB2 (0.66) | ERBB2EGFRSPHK1MAOAMAOB | |
| Hydrochloric Acid SCHEMBL7095291 | 0.99 | ERBB2 (0.65) | ERBB2EGFRSPHK1MAOAMAOB | |
| Hydrochloric Acid SCHEMBL7915742 | 0.99 | ERBB2 (0.65) | ERBB2EGFRSPHK1MAOAMAOB | |
| Hydrochloric Acid SCHEMBL7007235 | 0.99 | ERBB2 (0.65) | ERBB2EGFRSPHK1MAOAMAOB | |
| Dimethylamine SCHEMBL7099762 | 0.93 | ERBB2 (0.65) | ERBB2EGFRERBB4 | |
| SCHEMBL7012807 | 0.92 | ERBB2 (0.65) | ERBB2EGFRERBB4 | |
| SCHEMBL7010824 | 0.91 | ERBB2 (0.65) | ERBB2EGFRERBB4 | |
| SCHEMBL7007843 | 0.91 | ERBB2 (0.65) | ERBB2EGFRERBB4 | |
| SCHEMBL6766100 | 0.90 | ERBB2 (0.57) | ERBB2EGFRSPHK1 | |
| SCHEMBL6766107 | 0.90 | ERBB2 (0.57) | ERBB2EGFRSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0912572-B1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LTD (GB) | 2003-01-15 | — | — | EP | claimed |
| US-6207669-B1 | IN TREATMENT OF CANCER AND PSORIASIS | GLAXO WELLCOME INC. | 2001-03-27 | — | — | US | claimed |
| EP-0912572-B1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LTD (GB) | 2003-01-15 | — | — | EP | disclosed |
| US-6207669-B1 | IN TREATMENT OF CANCER AND PSORIASIS | GLAXO WELLCOME INC. | 2001-03-27 | — | — | US | disclosed |